MedPath
TGA Approval

SIGNIFOR LAR pasireotide 40 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack (225273)

225273

SIGNIFOR LAR pasireotide 40 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack

Recordati Rare Diseases Australia Pty Ltd

May 4, 2015

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/a6655d24f8cc0043aae915eda04af481.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/281956df96a097ee2b42f62825f37002.pdf

Active Ingredients

pasireotide embonate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SIGNIFOR LAR pasireotide 40 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack (225273) - TGA 批准文号 | MedPath